Global NGS Services Market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by the increasing demand for personalized medicine and growing number of research studies in various fields such as oncology, drug discovery, agriculture and diagnostics.
The global NGS services market is segmented into type (targeted, RNSeq, exome), application (diagnostics, oncology, drug discovery) and region (North America, Latin America Europe Asia Pacific Middle East & Africa). North America dominates the global NGS services market with a share of over 40%. The growth in this region can be attributed to the presence of major players such as Illumina Inc, Thermo Fisher Scientific Inc, Life Technologies Corporation and Roche Diagnostics GmbH.
-The Next-Generation Sequencing (NGS) Services market is expected to grow at a CAGR of 18.2% during the forecast period.
-The Next-Generation Sequencing (NGS) Services market is driven by factors such as increasing demand for personalized medicine, growing prevalence of chronic diseases, and technological advancements in sequencing technologies.
-Increasing demand for personalized medicine is driving the growth of the Next-Generation Sequencing (NGS) Services market. The increasing prevalence of chronic diseases and technological advancements in sequencing technologies are also driving the growth of this market.
Industry Growth Insights published a new data on “Next-Generation Sequencing (NGS) Services Market”. The research report is titled “Next-Generation Sequencing (NGS) Services Market research by Types (Targeted, RNA-Seq, Exome), By Applications (Diagnostics, Oncology, Drug Discovery, Agriculture), By Players/Companies BGI, Illumina, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen, Qiagen, Genotypic Technology, Genewiz, Dna Link, Takara, Scigenom Labs, Novogene, Personalis”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Next-Generation Sequencing (NGS) Services Market Research Report
By Type
Targeted, RNA-Seq, Exome
By Application
Diagnostics, Oncology, Drug Discovery, Agriculture
By Companies
BGI, Illumina, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen, Qiagen, Genotypic Technology, Genewiz, Dna Link, Takara, Scigenom Labs, Novogene, Personalis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
 Services Industry Outlook.svg)
Global Next-Generation Sequencing (NGS) Services Market Report Segments:
The global Next-Generation Sequencing (NGS) Services market is segmented on the basis of:
Types
Targeted, RNA-Seq, Exome
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics, Oncology, Drug Discovery, Agriculture
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BGI
- Illumina
- Perkinelmer
- Eurofins Scientific
- Gatc Biotech
- Macrogen
- Qiagen
- Genotypic Technology
- Genewiz
- Dna Link
- Takara
- Scigenom Labs
- Novogene
- Personalis
 Services Market Overview.svg)
Highlights of The Next-Generation Sequencing (NGS) Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Targeted
- RNA-Seq
- Exome
- By Application:
- Diagnostics
- Oncology
- Drug Discovery
- Agriculture
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Next-Generation Sequencing (NGS) Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Services Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Next-generation sequencing (NGS) services are a type of laboratory service that uses DNA sequencing technology to read the entire sequence of a gene or genome. This allows scientists to identify specific genes and their functions, as well as mutations and other changes in the genetic code. NGS can also be used to study how different genes interact with one another, which can help researchers develop new treatments for diseases.
Some of the major players in the next-generation sequencing (ngs) services market are BGI, Illumina, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen, Qiagen, Genotypic Technology, Genewiz, Dna Link, Takara, Scigenom Labs, Novogene, Personalis.
The next-generation sequencing (ngs) services market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Next-Generation Sequencing (NGS) Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Next-Generation Sequencing (NGS) Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Next-Generation Sequencing (NGS) Services Market - Supply Chain
4.5. Global Next-Generation Sequencing (NGS) Services Market Forecast
4.5.1. Next-Generation Sequencing (NGS) Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Next-Generation Sequencing (NGS) Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Next-Generation Sequencing (NGS) Services Market Absolute $ Opportunity
5. Global Next-Generation Sequencing (NGS) Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Type
5.3.1. Targeted
5.3.2. RNA-Seq
5.3.3. Exome
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Next-Generation Sequencing (NGS) Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
6.3.1. Diagnostics
6.3.2. Oncology
6.3.3. Drug Discovery
6.3.4. Agriculture
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Next-Generation Sequencing (NGS) Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Next-Generation Sequencing (NGS) Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Next-Generation Sequencing (NGS) Services Demand Share Forecast, 2019-2026
9. North America Next-Generation Sequencing (NGS) Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
9.4.1. Diagnostics
9.4.2. Oncology
9.4.3. Drug Discovery
9.4.4. Agriculture
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Type
9.7.1. Targeted
9.7.2. RNA-Seq
9.7.3. Exome
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Next-Generation Sequencing (NGS) Services Demand Share Forecast, 2019-2026
10. Latin America Next-Generation Sequencing (NGS) Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
10.4.1. Diagnostics
10.4.2. Oncology
10.4.3. Drug Discovery
10.4.4. Agriculture
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Type
10.7.1. Targeted
10.7.2. RNA-Seq
10.7.3. Exome
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Next-Generation Sequencing (NGS) Services Demand Share Forecast, 2019-2026
11. Europe Next-Generation Sequencing (NGS) Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
11.4.1. Diagnostics
11.4.2. Oncology
11.4.3. Drug Discovery
11.4.4. Agriculture
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Next-Generation Sequencing (NGS) Services arket Size and Volume Forecast by Type
11.7.1. Targeted
11.7.2. RNA-Seq
11.7.3. Exome
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Next-Generation Sequencing (NGS) Services Demand Share, 2019-2026
12. Asia Pacific Next-Generation Sequencing (NGS) Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
12.4.1. Diagnostics
12.4.2. Oncology
12.4.3. Drug Discovery
12.4.4. Agriculture
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Type
12.7.1. Targeted
12.7.2. RNA-Seq
12.7.3. Exome
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Next-Generation Sequencing (NGS) Services Demand Share, 2019-2026
13. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Application
13.4.1. Diagnostics
13.4.2. Oncology
13.4.3. Drug Discovery
13.4.4. Agriculture
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size and Volume Forecast by Type
13.7.1. Targeted
13.7.2. RNA-Seq
13.7.3. Exome
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Next-Generation Sequencing (NGS) Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Next-Generation Sequencing (NGS) Services Market: Market Share Analysis
14.2. Next-Generation Sequencing (NGS) Services Distributors and Customers
14.3. Next-Generation Sequencing (NGS) Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BGI
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Illumina
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Perkinelmer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eurofins Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Gatc Biotech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Macrogen
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Qiagen
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Genotypic Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Genewiz
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dna Link
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Takara
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Scigenom Labs
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Novogene
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Personalis
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
